CLEVELAND, March 10, 2026 /PRNewswire/ -- GenomOncology, a leading precision medicine software company, today announced a strategic partnership with WeTrials, an AI-powered patient engagement and ...
With aging populations on the rise, the need for better tools to diagnose and monitor Alzheimer's disease (AD), the most ...
With aging populations on the rise, the need for better tools to diagnose and monitor Alzheimer's disease (AD), the most common cause of dementia, has ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果